Viewing Study NCT00138567


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2025-12-25 @ 10:44 PM
Study NCT ID: NCT00138567
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2005-08-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module